Glaucoma represents one of medicine’s most paradoxical challenges—a leading cause of irreversible blindness worldwide that progresses so silently many patients have no idea they’re affected ...

If you’ve heard that smoking marijuana can treat glaucoma, we have an important tip: the rumor isn’t true. But experts at the John A. Moran Eye Center say they can direct you to the latest treatments ...

A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The promising results have been published in the journal Cell Reports Medicine.

Looking back, glaucoma specialists like Dr. Christine Funke of Barnet Dulaney Perkins Eye Center can remember a time not long ago when treatment options for the eye condition were greatly limited.

Concerns about glaucoma had a negative impact on medication adherence. Illness perception also had an impact on glaucoma-related quality of life. SALT LAKE CITY — Patients who had a worse ...

New Delhi: As a pioneering initiative of the Indian Army, the ophthalmology department at the Army Hospital (Research & Referral) here has performed a minimally invasive glaucoma surgery using a ...

Steven Mansberger, MD, MPH, Chief of Ophthalmology and Director of Glaucoma Services at Legacy Devers Eye Institute, and an Investigator in the study, shared the results today in an oral ...

Purpose To examine the association between (1) glaucoma and erectile dysfunction (ED) and (2) topical β-blocker (BB) use and ED. Methods A comprehensive, province-wide database of physician ...

This is not the same patient profile as in the Phase 3 glaucoma program. Safety and efficacy have already been demonstrated in the first Phase 3 clinical trial, Mont Blanc. The results of the Mont ...

Medicare covers glaucoma screening under Part B. For Medicare to cover it, the screening needs to be done or supervised by a doctor who is legally qualified and who accepts Medicare. Glaucoma is ...

Galimedix Therapeutics completed the single ascending dose part of a phase 1 study of GAL-101, a potential oral therapy under investigation for the treatment of glaucoma and dry age-related ...